This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
As of June 21, 2010, gemtuzumab ozogamicin is no longer available to new patients, due to concerns about whether the drug is safe and effective. Patients who are already being treated with this drug may continue their treatment, depending on their doctor's advice. To learn more, see Gemtuzumab Ozogamicin Voluntarily Withdrawn from U.S. Markets.
Gemtuzumab ozogamicin was originally approved to treat:
- Acute myeloid leukemia that had relapsed. It was used in patients 60 years or older who were not able to receive other chemotherapy.
Gemtuzumab ozogamicin continues to be studied in the treatment of leukemia and other conditions.
More About Gemtuzumab Ozogamicin
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Gemtuzumab Ozogamicin - Check for trials from NCI's list of cancer clinical trials now accepting patients.